Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 335 followers

Latest posts

Last updated about 15 hours ago

Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation: 26/06/2025, Revision: 3, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation...

Data in regulation: Big data and other sources

about 16 hours ago

Data in regulation: Big data and other sources

Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date of authorisation: 21/02/2006, Revision: 48, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date...

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 8, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date...

Orphan designation: dasatinib Treatment of Diamond-Blackfan anaemia, 22/06/2026 Positive

about 18 hours ago

Orphan designation: dasatinib Treatment of Diamond-Blackfan anaemia, 22/06/2026 Positive

Orphan designation: short hairpin RNA against NANOG mRNA Treatment of glioma, 23/06/2026 Positive

about 18 hours ago

Orphan designation: short hairpin RNA against NANOG mRNA Treatment of glioma, 23/06/2026...

Orphan designation: satralizumab Treatment of myelin oligodendrocyte glycoprotein antibody-associated disease, 22/06/2026 Positive

about 18 hours ago

Orphan designation: satralizumab Treatment of myelin oligodendrocyte glycoprotein antibody-associated disease, 22/06/2026 Positive

Orphan designation: humanised IgG4 monoclonal antibody against activated protein C Treatment of progressive multifocal leukoencephalopathy, 22/06/2026 Positive

about 18 hours ago

Orphan designation: humanised IgG4 monoclonal antibody against activated protein C Treatment of...

Orphan designation: (S)-Quinuclidin-3-yl((R)-5-(3-chloro-4-isopropoxyphenyl)-2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)carbamate ((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate Treatment of Gaucher disease, 22/06/2026 Positive

about 18 hours ago

Orphan designation: (S)-Quinuclidin-3-yl((R)-5-(3-chloro-4-isopropoxyphenyl)-2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)carbamate ((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate Treatment of Gaucher disease, 22/06/2026 Positive

Orphan designation: cyclo(arginyl-glycyl-aspartyl-D-tyrosyl-lysyl)-nizaracianine-1 Treatment of head and neck cancer, 22/06/2026 Positive

about 19 hours ago

Orphan designation: cyclo(arginyl-glycyl-aspartyl-D-tyrosyl-lysyl)-nizaracianine-1 Treatment of head and neck cancer, 22/06/2026 Positive